Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

1.

The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer.

Villadsen SB, Bramsen JB, Ostenfeld MS, Wiklund ED, Fristrup N, Gao S, Hansen TB, Jensen TI, Borre M, Ørntoft TF, Dyrskjøt L, Kjems J.

Br J Cancer. 2012 Jan 17;106(2):366-74. doi: 10.1038/bjc.2011.520. Epub 2011 Nov 22.

PMID:
22108519
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.

Pignot G, Cizeron-Clairac G, Vacher S, Susini A, Tozlu S, Vieillefond A, Zerbib M, Lidereau R, Debre B, Amsellem-Ouazana D, Bieche I.

Int J Cancer. 2013 Jun 1;132(11):2479-91. doi: 10.1002/ijc.27949. Epub 2013 Feb 25.

PMID:
23169479
[PubMed - indexed for MEDLINE]
3.

Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro.

Dyrskjøt L, Ostenfeld MS, Bramsen JB, Silahtaroglu AN, Lamy P, Ramanathan R, Fristrup N, Jensen JL, Andersen CL, Zieger K, Kauppinen S, Ulhøi BP, Kjems J, Borre M, Orntoft TF.

Cancer Res. 2009 Jun 1;69(11):4851-60. doi: 10.1158/0008-5472.CAN-08-4043.

PMID:
19487295
[PubMed - indexed for MEDLINE]
Free Article
4.

MicroRNA-126 inhibits invasion in bladder cancer via regulation of ADAM9.

Jia AY, Castillo-Martin M, Bonal DM, Sánchez-Carbayo M, Silva JM, Cordon-Cardo C.

Br J Cancer. 2014 Jun 10;110(12):2945-54. doi: 10.1038/bjc.2014.245. Epub 2014 May 13.

PMID:
24823697
[PubMed - indexed for MEDLINE]
5.

Involvement of miR-30c and miR-301a in immediate induction of plasminogen activator inhibitor-1 by placental growth factor in human pulmonary endothelial cells.

Patel N, Tahara SM, Malik P, Kalra VK.

Biochem J. 2011 Mar 15;434(3):473-82. doi: 10.1042/BJ20101585.

PMID:
21175428
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.

Hildenbrand R, Schaaf A.

Int J Oncol. 2009 Jan;34(1):15-23.

PMID:
19082473
[PubMed - indexed for MEDLINE]
7.

Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.

Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Uchida Y, Kawahara K, Nishiyama K, Seki N, Nakagawa M.

Urol Oncol. 2012 Jul-Aug;30(4):434-43. doi: 10.1016/j.urolonc.2010.05.008. Epub 2010 Sep 16.

PMID:
20843712
[PubMed - indexed for MEDLINE]
8.

miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors.

Ostenfeld MS, Bramsen JB, Lamy P, Villadsen SB, Fristrup N, Sørensen KD, Ulhøi B, Borre M, Kjems J, Dyrskjøt L, Orntoft TF.

Oncogene. 2010 Feb 18;29(7):1073-84. doi: 10.1038/onc.2009.395. Epub 2009 Nov 16.

PMID:
19915607
[PubMed - indexed for MEDLINE]
9.

Comparison of microarray-based RNA expression with ELISA-based protein determination of HER2, uPA and PAI-1 in tumour tissue of patients with breast cancer and relation to outcome.

Witzel ID, Milde-Langosch K, Wirtz RM, Roth C, Ihnen M, Mahner S, Zu Eulenburg C, Jänicke F, Müller V.

J Cancer Res Clin Oncol. 2010 Nov;136(11):1709-18. doi: 10.1007/s00432-010-0829-4. Epub 2010 Mar 4.

PMID:
20204407
[PubMed - indexed for MEDLINE]
10.

Analyses in human urothelial cells identify methylation of miR-152, miR-200b and miR-10a genes as candidate bladder cancer biomarkers.

Köhler CU, Bryk O, Meier S, Lang K, Rozynek P, Brüning T, Käfferlein HU.

Biochem Biophys Res Commun. 2013 Aug 16;438(1):48-53. doi: 10.1016/j.bbrc.2013.07.021. Epub 2013 Jul 16.

PMID:
23867826
[PubMed - indexed for MEDLINE]
11.

Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.

Biermann JC, Holzscheiter L, Kotzsch M, Luther T, Kiechle-Bahat M, Sweep FC, Span PN, Schmitt M, Magdolen V.

Int J Mol Med. 2008 Feb;21(2):251-9.

PMID:
18204793
[PubMed - indexed for MEDLINE]
12.

Prognostic impact of plasminogen activator inhibitor type 1 expression in bladder cancer.

Becker M, Szarvas T, Wittschier M, vom Dorp F, Tötsch M, Schmid KW, Rübben H, Ergün S.

Cancer. 2010 Oct 1;116(19):4502-12. doi: 10.1002/cncr.25326.

PMID:
20564745
[PubMed - indexed for MEDLINE]
Free Article
13.

A common MicroRNA signature consisting of miR-133a, miR-139-3p, and miR-142-3p clusters bladder carcinoma in situ with normal umbrella cells.

Jia AY, Castillo-Martin M, Domingo-Domenech J, Bonal DM, Sánchez-Carbayo M, Silva JM, Cordon-Cardo C.

Am J Pathol. 2013 Apr;182(4):1171-9. doi: 10.1016/j.ajpath.2013.01.006. Epub 2013 Feb 12.

PMID:
23410519
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

miR-421 and miR-30c inhibit SERPINE 1 gene expression in human endothelial cells.

Marchand A, Proust C, Morange PE, Lompré AM, Trégouët DA.

PLoS One. 2012;7(8):e44532. doi: 10.1371/journal.pone.0044532. Epub 2012 Aug 31.

PMID:
22952991
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer.

Puerta-Gil P, García-Baquero R, Jia AY, Ocaña S, Alvarez-Múgica M, Alvarez-Ossorio JL, Cordon-Cardo C, Cava F, Sánchez-Carbayo M.

Am J Pathol. 2012 May;180(5):1808-15. doi: 10.1016/j.ajpath.2012.01.034. Epub 2012 Mar 15.

PMID:
22426337
[PubMed - indexed for MEDLINE]
Free Article
16.

miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.

Luo Z, Dai Y, Zhang L, Jiang C, Li Z, Yang J, McCarthy JB, She X, Zhang W, Ma J, Xiong W, Wu M, Lu J, Li X, Li X, Xiang J, Li G.

Carcinogenesis. 2013 Feb;34(2):415-25. doi: 10.1093/carcin/bgs329. Epub 2012 Oct 24.

PMID:
23097559
[PubMed - indexed for MEDLINE]
Free Article
17.

A MicroRNA expression profile defining the invasive bladder tumor phenotype.

Wszolek MF, Rieger-Christ KM, Kenney PA, Gould JJ, Silva Neto B, Lavoie AK, Logvinenko T, Libertino JA, Summerhayes IC.

Urol Oncol. 2011 Nov-Dec;29(6):794-801.e1. doi: 10.1016/j.urolonc.2009.08.024. Epub 2009 Nov 27.

PMID:
19945312
[PubMed - indexed for MEDLINE]
18.

miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer.

Chiyomaru T, Enokida H, Tatarano S, Kawahara K, Uchida Y, Nishiyama K, Fujimura L, Kikkawa N, Seki N, Nakagawa M.

Br J Cancer. 2010 Mar 2;102(5):883-91. doi: 10.1038/sj.bjc.6605570. Epub 2010 Feb 16.

PMID:
20160723
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

MicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24.

Cao Y, Yu SL, Wang Y, Guo GY, Ding Q, An RH.

Tumour Biol. 2011 Feb;32(1):179-88. doi: 10.1007/s13277-010-0111-z. Epub 2010 Sep 21.

PMID:
20857258
[PubMed - indexed for MEDLINE]
20.

MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer.

Cheng CW, Wang HW, Chang CW, Chu HW, Chen CY, Yu JC, Chao JI, Liu HF, Ding SL, Shen CY.

Breast Cancer Res Treat. 2012 Aug;134(3):1081-93. doi: 10.1007/s10549-012-2034-4. Epub 2012 Apr 4.

PMID:
22476851
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk